Tysabri Clinical Trials Tysabri RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Natalizumab in Recurrent, Refractory or Progressive Pulmonary Metastatic Osteosarcoma
Condition:   Pulmonary Metastatic Osteosarcoma (pOS) Intervention:   Drug: Natalizumab Sponsor:   Case Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2019 Category: Research Source Type: clinical trials